Legal Representation
Attorney
Rachelle A. Dubow, Esq.
USPTO Deadlines
Application History
50 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Apr 8, 2013 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
Apr 8, 2013 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
Oct 10, 2012 | NOAC | E | CORRECTED NOA E-MAILED | Loading... |
Oct 10, 2012 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Oct 9, 2012 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
Oct 9, 2012 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
Sep 6, 2012 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
Sep 6, 2012 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
Sep 5, 2012 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Sep 5, 2012 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
Sep 5, 2012 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
Sep 5, 2012 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
Mar 9, 2012 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Mar 8, 2012 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
Mar 5, 2012 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Mar 5, 2012 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
Sep 3, 2011 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Sep 2, 2011 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
Aug 30, 2011 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Aug 30, 2011 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
Mar 17, 2011 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Mar 16, 2011 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Mar 8, 2011 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Mar 8, 2011 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
Feb 16, 2011 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
Feb 9, 2011 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Feb 9, 2011 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Nov 3, 2010 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Nov 2, 2010 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Oct 26, 2010 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
Oct 2, 2010 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
Oct 2, 2010 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
Oct 2, 2010 | TPEX | I | SOU EXTENSION RECEIVED WITH TEAS PETITION | Loading... |
Sep 9, 2010 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Mar 9, 2010 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Dec 15, 2009 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Dec 15, 2009 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Nov 10, 2009 | ALIE | A | ASSIGNED TO LIE | Loading... |
Nov 10, 2009 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
Oct 27, 2009 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Oct 27, 2009 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Oct 12, 2009 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Oct 12, 2009 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Oct 12, 2009 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Jun 28, 2009 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Jun 28, 2009 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Jun 28, 2009 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Jun 28, 2009 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Apr 15, 2009 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Apr 15, 2009 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals used in a pump, namely, glaucoma, macular degeneration, diabetic retinopathy, uveitis, retinitis pigmentosa pharmaceuticals; pharmaceuticals used in a pump, syringe or injector, namely, neurosurgery and orthopedic pharmaceuticals; pharmaceuticals used in a pump, syringe or injector, namely, insulin and antibody pharmaceuticals for subcutaneous administration
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005